International trade · 03/11/2011Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension for SURFAXIN® Patent
Summary
The U.S. Patent and Trademark Office has issued an Order Granting Interim Extension for a third one-year interim extension of the term of U.S. Patent No. 5,407,914, which covers the SURFAXIN® (Lucinactant) medication.
Original source language: Federal Register — Department of CommerceOpen original release →